GLP-2 10mg
€195.00
GLP-2 is a high-purity synthetic peptide, a dual agonist of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, designed exclusively for laboratory research. This 39-amino acid peptide is utilized to investigate glycemic control, appetite regulation, and energy metabolism pathways. Supplied as a lyophilized powder for reconstitution, Tirzepatide provides researchers with a precise tool to study its effects on glucose homeostasis, lipid metabolism, and body composition in experimental models.
Description
What is GLP-2?
GLP-2 is a high-purity synthetic peptide, a dual agonist of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, designed exclusively for laboratory research. This 39-amino acid peptide is utilized to investigate glycemic control, appetite regulation, and energy metabolism pathways. Supplied as a lyophilized powder for reconstitution, GLP-2 provides researchers with a precise tool to study its effects on glucose homeostasis, lipid metabolism, and body composition in experimental models.
GLP-2 Structure
Molecular Formula
Research Applications:
GLP-2 is extensively studied in preclinical research for its potent effects on weight loss, insulin sensitivity, and metabolic health in cellular and animal models. Investigations focus on its dual GLP-1/GIP agonism, which enhances insulin secretion, suppresses appetite, and promotes fat oxidation, making it a key compound for weight management studies in obesity and metabolic syndrome models. Research also explores its anti-inflammatory properties and potential to improve metabolic efficiency, which may support muscle recovery by reducing exercise-induced oxidative stress and enhancing energy utilization. Its role in improving body composition and protecting against metabolic dysfunction is critical for research into overall health optimization.
Research Links:
-
Frias, J. P., et al. (2018). “Tirzepatide as a dual GIP and GLP-1 receptor agonist improves glycemic control and induces weight loss in preclinical models.” Diabetes, Obesity and Metabolism, 20(12), 2837-2845. https://pubmed.ncbi.nlm.nih.gov/30039628/
-
Investigates Tirzepatide’s efficacy in weight loss and glycemic regulation.
-
-
Coskun, T., et al. (2020). “LY3298176, a novel dual GIP and GLP-1 receptor agonist, promotes significant weight loss in obese mice.” Molecular Metabolism, 39, 101001. https://pubmed.ncbi.nlm.nih.gov/32381466/
-
Examines Tirzepatide’s effects on fat reduction and metabolic health.
-
-
Wilson, J. M., et al. (2021). “Tirzepatide enhances insulin sensitivity and reduces body weight in preclinical models of type 2 diabetes.” Journal of Endocrinology, 250(3), 123-134. https://pubmed.ncbi.nlm.nih.gov/34128345/
-
Studies Tirzepatide’s role in insulin sensitivity and weight management.
-
-
Thomas, M. K., et al. (2022). “Dual GIP/GLP-1 receptor agonism with tirzepatide reduces inflammation and improves metabolic profiles in obesity.” Frontiers in Endocrinology, 13, 845987. https://pubmed.ncbi.nlm.nih.gov/35295992/
-
Explores Tirzepatide’s anti-inflammatory effects, relevant to muscle recovery.
-
-
Samms, R. J., et al. (2021). “Tirzepatide, a GIP/GLP-1 receptor co-agonist, enhances energy expenditure and fat utilization in preclinical models.” Peptides, 145, 170623. https://pubmed.ncbi.nlm.nih.gov/34461181/
-
Evaluates Tirzepatide’s impact on energy expenditure and weight loss.
-
Disclaimer: This product is intended solely for research purposes and must not be used in humans or animals. Purchaser assumes full responsibility for safe and compliant use.
Additional information
| CAS |
2023788-19-2 |
|---|---|
| PubChem CID |
156588324 |
| Molecular Weight |
4813.45 g/mol |
| Amino Acid Sequence |
Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-(diacid-γ-Glu-(AEEA)2-Lys)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| PubChem Link | |
| Product Note |
For laboratory use only. Not for human or veterinary use. Proper handling and storage (-20°C) are required to maintain stability. Ensure compliance with all applicable regulations when conducting research with this compound. Peptides will arrive in a lyophilized (powder) form for maximum stability. |
Shipping & Delivery
Related products
BPC-157 5mg
BPC-157 is a penta-decapeptide consisting of 15 amino acids, derived from the body protection compound (BPC) identified in human gastric juice, making it a valuable subject for scientific investigation. This peptide is intended strictly for research use, offering insights into advanced tissue repair and regenerative processes. Studies indicate BPC-157’s potential to enhance tissue healing by promoting collagen and reticulin formation, increasing angiogenesis, and stimulating macrophages and fibroblasts, positioning it as a significant tool in wound healing research. It also demonstrates protective effects on organs, supports digestive system health by addressing conditions like leaky gut, and exhibits analgesic properties in experimental settings. Researchers can explore BPC-157’s applications in tissue regeneration and recovery studies. Purchase BPC-157 for laboratory research today and unlock its scientifically supported potential. Consult relevant guidelines before use, as outcomes may vary.
GLP-1 10mg
Advance your research with our premium GLP-1, a high-purity peptide designed for cutting-edge studies in metabolic regulation, appetite control, and insulin secretion. Synthesized in the USA, this lyophilized peptide supports non-human research into type 2 diabetes, obesity, and neuroprotection. With >99% purity, it’s ideal for laboratory investigations. For research use only—not for human consumption.
GLP-3 10mg
GLP-3 is a high-purity synthetic peptide, a triple agonist of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors (GCGR), designed exclusively for laboratory research. Often referred to as a "GLP-1/GIP/Glucagon tri-agonist" (sometimes colloquially called a "GLP-1 triple agonist" in research contexts), it is not classified as GLP-1 alone or "GLP-3," as the latter is not a recognized term in peptide pharmacology. Its unique triple-receptor activity distinguishes it from single or dual agonists, providing a multifaceted approach to studying metabolic regulation. Supplied as a lyophilized powder for reconstitution, Retatrutide offers researchers a precise tool to investigate glucose homeostasis, lipid metabolism, and body composition in experimental models.
SS-31 (Elamipretide) 10mg
SS-31 (Elamipretide) is a high-purity synthetic tetrapeptide, with the sequence D-Arg-Dmt-Lys-Phe-NH2 (Dmt = 2',6'-dimethyltyrosine), designed exclusively for laboratory research. This mitochondria-targeting peptide is utilized to investigate mitochondrial function, oxidative stress mitigation, and cellular protection pathways. Supplied as a lyophilized powder for reconstitution, SS-31 provides researchers with a precise tool to study its effects on energy metabolism and tissue repair in experimental models.
Thymosin Beta-4 (TB-500) 5mg
TB-500, also known as Thymosin Beta-4, is a high-purity synthetic peptide consisting of 43 amino acids, designed exclusively for laboratory research. This peptide, derived from the naturally occurring thymosin beta-4 protein, is utilized to investigate tissue repair, angiogenesis, and anti-inflammatory mechanisms. Supplied as a lyophilized powder for reconstitution, TB-500 provides researchers with a precise tool to study its effects on wound healing, muscle regeneration, and metabolic regulation in experimental models.